169 related articles for article (PubMed ID: 33082300)
1.
Yong AC; Tan YJ; Zhao Y; Lu Z; Ng EY; Ng SY; Chia NS; Choi X; Heng D; Neo S; Xu Z; Tay KY; Au WL; Tan EK; Tan LC; Ng AS
Aging (Albany NY); 2020 Oct; 12(20):20880-20887. PubMed ID: 33082300
[TBL] [Abstract][Full Text] [Related]
2. SNCA Rep1 promoter variability influences cognition in Parkinson's disease.
Ng ASL; Tan YJ; Zhao Y; Saffari SE; Lu Z; Ng EYL; Ng SYE; Chia NSY; Setiawan F; Xu Z; Tay KY; Au WL; Tan LCS; Tan EK
Mov Disord; 2019 Aug; 34(8):1232-1236. PubMed ID: 31234238
[TBL] [Abstract][Full Text] [Related]
3. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
[TBL] [Abstract][Full Text] [Related]
4. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
[TBL] [Abstract][Full Text] [Related]
5. Head injury, α-synuclein Rep1, and Parkinson's disease.
Goldman SM; Kamel F; Ross GW; Jewell SA; Bhudhikanok GS; Umbach D; Marras C; Hauser RA; Jankovic J; Factor SA; Bressman S; Lyons KE; Meng C; Korell M; Roucoux DF; Hoppin JA; Sandler DP; Langston JW; Tanner CM
Ann Neurol; 2012 Jan; 71(1):40-8. PubMed ID: 22275250
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson's Disease.
Tan YJ; Saffari SE; Zhao Y; Ng EYL; Yong ACW; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Tay KY; Au WL; Tan EK; Tan LCS; Ng ASL
J Parkinsons Dis; 2022; 12(3):865-870. PubMed ID: 35068417
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
Ritz B; Rhodes SL; Bordelon Y; Bronstein J
PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
[TBL] [Abstract][Full Text] [Related]
8. The Length of
Corrado L; De Marchi F; Tunesi S; Oggioni GD; Carecchio M; Magistrelli L; Tesei S; Riboldazzi G; Di Fonzo A; Locci C; Trezzi I; Zangaglia R; Cereda C; D'Alfonso S; Magnani C; Comi GP; Bono G; Pacchetti C; Cantello R; Goldwurm S; Comi C
Front Neurol; 2018; 9():213. PubMed ID: 29662465
[TBL] [Abstract][Full Text] [Related]
9. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.
Brighina L; Schneider NK; Lesnick TG; de Andrade M; Cunningham JM; Mrazek D; Rocca WA; Maraganore DM
Parkinsonism Relat Disord; 2009 Jul; 15(6):430-4. PubMed ID: 19196539
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
[TBL] [Abstract][Full Text] [Related]
12. The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome.
Lahut S; Vadasz D; Depboylu C; Ries V; Krenzer M; Stiasny-Kolster K; Basak AN; Oertel WH; Auburger G
Neurogenetics; 2014 Aug; 15(3):189-92. PubMed ID: 24863655
[TBL] [Abstract][Full Text] [Related]
13. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
[TBL] [Abstract][Full Text] [Related]
16. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
[TBL] [Abstract][Full Text] [Related]
17. SNCA REP1 and Parkinson's disease.
Shu L; Zhang Y; Sun Q; Pan H; Guo J; Tang B
Neurosci Lett; 2018 Aug; 682():79-84. PubMed ID: 29859327
[TBL] [Abstract][Full Text] [Related]
18. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
[TBL] [Abstract][Full Text] [Related]
19. SNCA-Rep1 polymorphism correlates with susceptibility and iron deficiency in restless legs syndrome.
Zhu XY; Wang HM; Wu TT; Liu T; Chen YJ; Li X; Chen TJ; Liu Y; Zhang XJ; Wang XX; Zhang Y; Ondo WG; Wu YC
Parkinsonism Relat Disord; 2020 Dec; 81():12-17. PubMed ID: 33035800
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]